Edges in Network
| Network | GSE16446_top500tf - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | NFE2L2 |
| Upstream (Parents) |
|---|
| (<<) ELF5 → NFE2L2 |
| (<<) FOXC2 → NFE2L2 |
| (<<) XBP1 → NFE2L2 |
| (<<) TULP4 → NFE2L2 |
| (<<) NFATC1 → NFE2L2 |
| (<<) RORA → NFE2L2 |
| (<<) KDM5A → NFE2L2 |
| (<<) ZNF217 → NFE2L2 |
| (<<) SP1 → NFE2L2 |
| (<<) TFCP2 → NFE2L2 |
| (<<) TFAM → NFE2L2 |
| (<<) SP3 → NFE2L2 |
| (<<) KLF7 → NFE2L2 |
| (<<) ADNP → NFE2L2 |
| (<<) FOXO1 → NFE2L2 |
| (<<) GCFC1 → NFE2L2 |
| (<<) MSL3 → NFE2L2 |
| (<<) ELF1 → NFE2L2 |
| Downstream (Children) |
|---|
| NFE2L2 → IRX4 (>>) |
| NFE2L2 → MNX1 (>>) |
| NFE2L2 → RBCK1 (>>) |
| NFE2L2 → GRHL2 (>>) |
| NFE2L2 → SALL2 (>>) |
| NFE2L2 → LASS2 (>>) |
